Bryan Ayers (brynta at expert.cc.purdue.edu) wrote:
: In article <32ab31c9.6568653 at news.wco.com>, Steve Gill <skg at asis.com> wrote:
: >On Mon, 02 Dec 1996 01:21:20 GMT, Cyrano at beehive.twics.com (Claude de
: >Contrecoeur) wrote:
: >>GHB(Gamma-Hydroxybutyrate).
: >One of the problems with GHB and other "orphan drugs" is that even if
: >new applications are found, the non-patentable status of the compound
: >assures that little money will be spent on clinical research due to
: >the low profit potential of the medication.
There's plenty of profit for someone who knows how to get it; there's
just not as much for a brand new, more expensive drug.